.jpg?format=webp&quality=80&width=3840)
Transcatheter aortic valve implantation (TAVI) in low-risk patients with severe aortic stenosis compares favourably with surgical aortic valve replacement (SAVR) in terms of all-cause mortality or disabling stroke at 3 years. This finding from the Evolut Low Risk study was presented at the ACC.23 conference.
Like
Save
Share